ABGABEVORRICHTUNG
European patent · EP2847096 · Deleted
Register entry
- Publication number
- EP2847096
- Application number
- EP13721757
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- May 9, 2013
- Published
- Mar 18, 2015
- Granted
- Mar 16, 2016
- Deleted
- Dec 23, 2021
- Reason
- Annual fee unpaid
- IPC classes
- B65D 83/04 (2006.01)B65D 83/06 (2006.01)
- Priority
- EP 12167791 11.05.2012
- PCT application
- PCT/EP2013/059691 09.05.2013
- PCT publication
- WO2013/167715 14.11.2013
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Dec 23, 2021
Deleted, fee unpaid
Published in Swissreg on 23.12.2021
- May 16, 2020
Agent entered
- Representative
- BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3013 Bern
Published in Swissreg on 16.05.2020
- May 16, 2020
Transferred
- Owner
- Novartis AG, Lichtstrasse 35, 4056 Basel → Phillips-Medisize A/S, Gimsinglundvej 20, 7600 Struer, Denmark
Published in Swissreg on 16.05.2020
- Mar 16, 2016
Granted
Published in Swissreg on 16.03.2016
Parties
Inventor
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.